BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. G-protein-coupled receptor binding, Lung cancer, Leukocyte, Hematopoietic cell)
Bookmark Forward

QuickView for CYBB;jsessionid=CFA0FC713E82BE062E17FE9E202B6173;jsessionid=6DD5F38F51BD009EC2008B205A5428F4;jsessionid=CCE7CFB139498398AB3B8348175ECC82 (gene)


Body Atlas

Most Correlated Tissues

  1. Monocyte of peripheral blood
  2. Myeloid cells of peripheral blood
  3. Mononuclear cell of peripheral blood
  4. Microglial cell
  5. Macrophage of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hereditary white blood cell disorder
  2. Disorder of neutrophils
  3. Caseating tuberculoid granuloma
  4. Bacterial pneumonia
  5. Disease caused by parasite
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Didanosine
  2. Kanamycin
  3. Prazosin Hydrochloride
  4. Benzodiazepines
  5. Copaxone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. TGFBR1
  2. NFIX
  3. SP110
  4. CYBB
  5. RPL10A
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Chronic Intermittent Hypoxia-Induced Diaphragm Muscle Weakness Is NADPH Oxidase-2 Dependent.
  2. Activation of neuronal NADPH oxidase NOX2 promotes inflammatory neurodegeneration.
  3. Neutrophil and Macrophage NADPH Oxidase 2 Differentially Control Responses to Inflammation and to As…
  4. Nox2 underpins microvascular inflammation and vascular contributions to cognitive decline.
  5. Macrophage NOX2 NADPH oxidase maintains alveolar homeostasis in mice.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for CYBB;jsessionid=CFA0FC713E82BE062E17FE9E202B6173;jsessionid=6DD5F38F51BD009EC2008B205A5428F4;jsessionid=CCE7CFB139498398AB3B8348175ECC82
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.